title: Malignant pleural mesothelioma: an epidemiological perspective.
abstract: This paper reviews the aetiology, distribution and projected future incidence of malignant mesothelioma. Asbestos exposure is the most thoroughly established risk factor. Debate continues regarding the relative importance of the different asbestos fibre types and the contribution of Simian virus 40 (SV40). Disease incidence varies markedly within and between countries. The highest annual rates of disease, approximately 30 case per million, are reported in Australia and Great Britain. The risk of disease increases with age and is higher in men. Time from asbestos exposure to disease diagnosis is on average greater than 40 years. Non-occupational asbestos exposures contribute an increasing proportion of disease. With the exception of the United States, incidence continues to increase. In developed countries peak incidence is expected to occur before 2030.
authors: The Baird Institute for Applied Heart and Lung Surgical Research, Sydney, Australia.
authors: Benjamin M
authors: BM
authors: Robinson
keywords: Asbestos; epidemiology; incidence; malignant mesothelioma
references: Lancet. 2004 Sep 25-Oct 1;364(9440):1157-66
references: 15451223
references: Am J Epidemiol. 2004 Jan 15;159(2):107-12
references: 14718210
references: Scand J Work Environ Health. 2007 Aug;33(4):286-92
references: 17717621
references: BMC Cancer. 2009 Jan 23;9:28
references: 19166594
references: Occup Environ Med. 2007 Nov;64(11):747-52
references: 17449562
references: Am J Ind Med. 2002 Mar;41(3):188-201
references: 11920963
references: Ind Health. 2007 Jun;45(3):379-87
references: 17634686
references: J Thorac Oncol. 2010 Nov;5(11):1841-8
references: 20975379
references: Am J Pathol. 1993 May;142(5):1524-33
references: 8388174
references: Curr Treat Options Oncol. 2008 Jun;9(2-3):147-57
references: 18709470
references: Scand J Work Environ Health. 2002 Dec;28(6):411-7
references: 12539801
references: Int J Cancer. 2005 May 20;115(1):142-7
references: 15645436
references: Crit Rev Toxicol. 2006 Feb;36(2):165-87
references: 16736942
references: Cancer Sci. 2012 Oct;103(10):1751-5
references: 22726320
references: Am J Ind Med. 2011 Jun;54(6):467-9
references: 21452191
references: Am J Ind Med. 2006 Jan;49(1):1-7
references: 16362942
references: Med J Aust. 2011 Sep 5;195(5):271-4
references: 21895596
references: Am J Ind Med. 2012 Jan;55(1):11-24
references: 22025020
references: Br J Ind Med. 1988 Jan;45(1):5-13
references: 2829959
references: Ann Occup Hyg. 2000 Dec;44(8):565-601
references: 11108782
references: Br J Cancer. 2006 Sep 4;95(5):649-52
references: 16909142
references: Occup Med (Lond). 2005 Mar;55(2):79-87
references: 15757980
references: N Engl J Med. 2005 Oct 13;353(15):1591-603
references: 16221782
references: Ann Epidemiol. 2011 Sep;21(9):688-97
references: 21820631
references: Br J Cancer. 2012 Feb 28;106(5):1016-20
references: 22315054
references: Int J Cancer. 2012 May 1;130(9):2146-54
references: 21647880
references: J Occup Environ Med. 2004 Jan;46(1):84-9
references: 14724482
references: Ann N Y Acad Sci. 1991 Dec 31;643:196-204
references: 1809132
references: Cancer Res. 2005 Nov 15;65(22):10273-9
references: 16288015
references: Environ Health Perspect. 2011 May;119(5):695-700
references: 21193386
references: Eur J Cancer. 2007 Dec;43(18):2722-8
references: 17980576
references: Environ Health Perspect. 2011 Apr;119(4):514-8
references: 21463977
references: Thorax. 2007 Nov;62 Suppl 2:ii1-ii19
references: 17965072
references: Ann Occup Hyg. 2010 Nov;54(8):851-7
references: 21059834
references: Mol Carcinog. 1999 Oct;26(2):93-9
references: 10506753
references: Occup Environ Med. 2010 Nov;67(11):792-4
references: 20959396
references: Semin Oncol. 2002 Feb;29(1):18-25
references: 11836665
references: Occup Med (Lond). 2003 May;53(3):209-12
references: 12724555
references: Lancet. 2001 Feb 10;357(9254):444-5
references: 11273069
references: Eur Respir J. 1996 Sep;9(9):1932-42
references: 8880114
references: Crit Rev Toxicol. 2009;39(7):576-88
references: 19650718
references: Cancer Biol Ther. 2002 Jul-Aug;1(4):348-53
references: 12432244
references: Int J Occup Environ Health. 2004 Jul-Sep;10(3):251-5
references: 15473077
references: J Natl Cancer Inst. 1979 Jul;63(1):17-22
references: 286826
references: Occup Environ Med. 2003 Jan;60(1):50-5
references: 12499457
references: Br J Cancer. 2005 Feb 14;92(3):587-93
references: 15668716
references: Br J Ind Med. 1960 Oct;17:260-71
references: 13782506
references: Bull World Health Organ. 2011 Oct 1;89(10):716-24, 724A-724C
references: 22084509
references: Chest. 2002 Dec;122(6):2224-9
references: 12475867
references: Cancer. 1992 Jun 1;69(11):2704-11
references: 1571901
references: Lancet. 1995 Mar 4;345(8949):535-9
references: 7776771
references: Ind Health. 2012;50(3):197-204
references: 22453207
references: Int J Cancer. 1993 Jun 19;54(4):578-81
references: 8390408
references: Occup Environ Med. 1999 Aug;56(8):505-13
references: 10492646